EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

PTGER3 knockdown inhibits the vulnerability of triple‐negative breast cancer to ferroptosis

Song Wang, Yueyao Zhang, Dan Zhang, Jie Meng, Na Che, Xiulan Zhao, Tieju Liu iD

Cancer Science · 2024

DOI: 10.1111/cas.16169 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Science, 2024. Verfasst von Song Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Tianjin Medical University, Tianjin, China. Hauptthemen laut MEDLINE: Cell Proliferation, Ferroptosis, Receptors, Prostaglandin E, EP3 Subtype, Triple Negative Breast Neoplasms. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prostaglandin E receptor 3 (PTGER3) is involved in a variety of biological processes in the human body and is closely associated with the development and progression of a variety of cancer types. However, the role of PTGER3 in triple‐negative breast cancer (TNBC) remains unclear. In the present study, low PTGER3 expression was found to be associated with poor prognosis in TNBC patients. PTGER3 plays a crucial role in regulating TNBC cell invasion, migration, and proliferation. Upregulation of PTGER3 weakens the epithelial–mesenchymal phenotype in TNBC and promotes ferroptosis both in vitro and in vivo by repressing glutathione peroxidase 4 (GPX4) expression. On the other hand, downregulation of PTGER3 inhibits ferroptosis by increasing GPX4 expression and activating the PI3K‐AKT pathway. Upregulation of PTGER3 also enhances the sensitivity of TNBC cells to paclitaxel. Overall, this study has elucidated critical pathways in which low PTGER3 expression protects TNBC cells from undergoing ferroptosis, thereby promoting its progression. PTGER3 may thus serve as a novel and promising biomarker and therapeutic target for TNBC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell ProliferationFerroptosisReceptors, Prostaglandin E, EP3 SubtypeTriple Negative Breast NeoplasmsAnimalsFemaleHumansMiceCell Line, TumorCell MovementEpithelial-Mesenchymal TransitionGene Expression Regulation, NeoplasticGene Knockdown TechniquesPaclitaxelPhospholipid Hydroperoxide Glutathione PeroxidasePrognosisSignal Transduction

Stichwörter der Autor:innen

GPX4PI3K‐AKTPTGER3ferroptosistriple‐negative breast cancer

Substanzen

PaclitaxelPhospholipid Hydroperoxide Glutathione PeroxidasePTGER3 protein, humanReceptors, Prostaglandin E, EP3 Subtype

Autor:innen und Institutionen

  • Department of Pathology, Tianjin Medical University, Tianjin, China.
  • Department of Pathology, Tianjin Medical University General Hospital, Tianjin, China.

ORCID-Profile: Tieju Liu

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Wang, S., Zhang, Y., Zhang, D., Meng, J., Che, N., Zhao, X., & Liu, T. (2024). PTGER3 knockdown inhibits the vulnerability of triple‐negative breast cancer to ferroptosis. Cancer Science. https://doi.org/10.1111/cas.16169

Vancouver

Wang S, Zhang Y, Zhang D, Meng J, Che N, Zhao X, et al. PTGER3 knockdown inhibits the vulnerability of triple‐negative breast cancer to ferroptosis. Cancer Science. 2024. doi:10.1111/cas.16169

BibTeX
@article{Wang2024,
  author = {Wang, Song and Zhang, Yueyao and Zhang, Dan and Meng, Jie and Che, Na and Zhao, Xiulan and Liu, Tieju},
  title = {PTGER3 knockdown inhibits the vulnerability of triple‐negative breast cancer to ferroptosis},
  journal = {Cancer Science},
  year = {2024},
  doi = {10.1111/cas.16169}
}
Kostenlos starten →